Lidocaine for migraine disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jan 2026: Trial registered, NCT07361549
  2. 9 Sep 2026: Trial started, NCT07361549

The trials

NCT07361549: Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment

State
Under way
Phase
Phase 2
People
80 planned
Started
9 Sep 2026
Primary completion
Dec 2030
Arms
Treatment
Results
None posted
  1. 23 Jan 2026: Trial registered
  2. 9 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Alphacaine, Bondlido, Dentipatch, Fortacin component lidocaine, Lidoderm, Lidocaine (drug), Paracervical block- Lidocaine without epinephrine, Ztlido.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.